| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.6 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.03 | 0.6 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.092 | 0.6 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.6 |